Literature DB >> 22173871

The tuberculosis drug streptomycin as a potential cancer therapeutic: inhibition of miR-21 function by directly targeting its precursor.

Debojit Bose1, Gopal Jayaraj, Hemant Suryawanshi, Prachi Agarwala, Subrata Kumar Pore, Rajkumar Banerjee, Souvik Maiti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22173871     DOI： 10.1002/anie.201106455

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN： 1433-7851            Impact factor:   15.336


× No keyword cloud information.
  54 in total

1.  MicroRNA from tuberculosis RNA: A bioinformatics study.

Authors:  Somsri Wiwanitkit; Viroj Wiwanitkit
Journal:  J Thorac Dis       Date:  2012-06-01       Impact factor: 2.895

2.  Design of RNA-targeting macrocyclic peptides.

Authors:  Matthew J Walker; Gabriele Varani
Journal:  Methods Enzymol       Date:  2019-06-13       Impact factor: 1.600

3.  Bleomycin Can Cleave an Oncogenic Noncoding RNA.

Authors:  Alicia J Angelbello; Matthew D Disney
Journal:  Chembiochem       Date:  2017-11-22       Impact factor: 3.164

4.  MicroRNAs as mediators of cardiovascular disease: Targets to be manipulated.

Authors:  Seahyoung Lee; Eunhyun Choi; Sung-Man Kim; Ki-Chul Hwang
Journal:  World J Biol Chem       Date:  2015-05-26

Review 5.  Small molecules with big roles in microRNA chemical biology and microRNA-targeted therapeutics.

Authors:  Rengen Fan; Chaocheng Xiao; Xinqiang Wan; Wenzhang Cha; Yufeng Miao; Yong Zhou; Chenglin Qin; Ting Cui; Fenglian Su; Xiangxiang Shan
Journal:  RNA Biol       Date:  2019-04-03       Impact factor: 4.652

Review 6.  MicroRNAs as novel endogenous targets for regulation and therapeutic treatments.

Authors:  Wenzhang Cha; Rengen Fan; Yufeng Miao; Yong Zhou; Chenglin Qin; Xiangxiang Shan; Xinqiang Wan; Ting Cui
Journal:  Medchemcomm       Date:  2017-12-11       Impact factor: 3.597

7.  Micellar Delivery of miR-34a Modulator Rubone and Paclitaxel in Resistant Prostate Cancer.

Authors:  Di Wen; Yang Peng; Feng Lin; Rakesh K Singh; Ram I Mahato
Journal:  Cancer Res       Date:  2017-04-20       Impact factor: 12.701

Review 8.  Approaches to Validate and Manipulate RNA Targets with Small Molecules in Cells.

Authors:  Jessica L Childs-Disney; Matthew D Disney
Journal:  Annu Rev Pharmacol Toxicol       Date:  2015-10-22       Impact factor: 13.820

9.  A Macrocyclic Peptide Ligand Binds the Oncogenic MicroRNA-21 Precursor and Suppresses Dicer Processing.

Authors:  Matthew D Shortridge; Matthew J Walker; Tom Pavelitz; Yu Chen; Wen Yang; Gabriele Varani
Journal:  ACS Chem Biol       Date:  2017-05-02       Impact factor: 5.100

Review 10.  Small molecules targeting microRNA for cancer therapy: Promises and obstacles.

Authors:  Di Wen; Michael Danquah; Amit Kumar Chaudhary; Ram I Mahato
Journal:  J Control Release       Date:  2015-08-06       Impact factor: 9.776
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.